The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3

Pulmonary Circulation 2026 Open access

Read full text
Authors: Katherine Bunclark, Joseph Newman, Hakim Ghani, Shiv Munagala, Eva Otter, Gerald Fischer, Marcin Kurzyna, Gergely Mészáros, Millicent Stone, Shahin Moledina, Luke Howard, Wendy Gin‐Sing
+5 more Pisana Ferrari, Maurice Beghetti, Mark Toshner, Matt Granato, Joanna Pepke‐Zaba
DOI: 10.1002/pul2.70256
Cited by: 1
References: 10

Abstract

In this first global study of patient perspectives in Group 2 and 3 PH, we demonstrate that those with Group 3 PH report significantly greater adverse impacts on physical and mental wellbeing than those in Group 2 or Group 1, despite a lower treatment side-effect profile.

Fields of Study & Subjects

Pulmonary Hypertension Research and Treatments Blood Pressure and Hypertension Studies Heart Failure Treatment and Management

Publication details

Journal / source
Pulmonary Circulation
Publisher
Wiley
Volume
16
Issue
1
Pages
e70256–e70256
Publication date
1 January 2026
Language
EN